Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - OtherWages, Salaries and Other
Ratios

Capricor Therapeutics (CAPR) Long-Term Debt Issuances (2016 - 2018)

Capricor Therapeutics has reported Long-Term Debt Issuances over the past 7 years, most recently at -$139140.0 for Q2 2018.

  • Quarterly results put Long-Term Debt Issuances at -$139140.0 for Q2 2018, down 155.66% from a year ago — trailing twelve months through Sep 2019 was -$139140.0 (down 155.66% YoY), and the annual figure for FY2020 was $318160.0, changed.
  • Long-Term Debt Issuances for Q2 2018 was -$139140.0 at Capricor Therapeutics, down from $139140.0 in the prior quarter.
  • Over the last five years, Long-Term Debt Issuances for CAPR hit a ceiling of $2.0 million in Q2 2016 and a floor of -$139140.0 in Q2 2018.
  • Median Long-Term Debt Issuances over the past 4 years was $250000.0 (2017), compared with a mean of $576417.7.
  • Biggest five-year swings in Long-Term Debt Issuances: tumbled 87.5% in 2017 and later plummeted 155.66% in 2018.
  • Capricor Therapeutics' Long-Term Debt Issuances stood at -$6667.0 in 2014, then soared by 26348.69% to $1.8 million in 2016, then crashed by 85.71% to $250000.0 in 2017, then plummeted by 155.66% to -$139140.0 in 2018.
  • The last three reported values for Long-Term Debt Issuances were -$139140.0 (Q2 2018), $139140.0 (Q1 2018), and $250000.0 (Q4 2017) per Business Quant data.